Press Release: Peloton Advantage : Petsky Prunier Advises Peloton Advantage on its Growth Investment from Amulet Capital Partners

Petsky Prunier is pleased to announce it has advised Peloton Advantage, LLC, a leading provider of best-in-class, clinically-focused strategic consulting and scientific communication advisory services to pharmaceutical, biotechnology, and medical device companies, on its growth investment from Amulet Capital Partners, a middle-market private equity investment firm focused exclusively on the healthcare sector